v3.26.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
Schedule of Effective Income Tax Rate

A reconciliation of the Company’s effective income tax rate to the U.S. statutory federal income tax rate of 21% for the years ended December 31, 2025 and 2024 is as follows:

 

   Years ended December 31, 
   2025   2024 
U.S. federal statutory income tax rate  $(598)   21.0%  $(1,519)   21.0%
Domestic Federal                    
Tax Credits                    
Research credits   (73)   2.6%   (290)   4.0%
Nontaxable and nondeductible items                    
Reversal of Excise tax and penalties   (924)   32.5%   -    0.0%
Loss on conversion of note   237    -8.3%   -    0.0%
Stock Issuance Costs   251    -8.8%   -    0.0%
Success Based Fees   -    0.0%   (127)   1.8%
Other permanent differences   8    -0.3%   29    -0.4%
Change in valuation allowance   1,099    -38.6%   1,906    -26.4%
Income tax expense  $-    0.0%  $-    0.0%
Schedule of Net Deferred Tax Assets and Liabilities

Significant components of the Company’s net deferred tax assets and liabilities as of December 31, 2025 and 2024 are as follows:

 

   Years ended December 31, 
   2025   2024 
Deferred tax assets:        
Operating loss carryforwards  $25,089   $23,229 
Tax credits   2,579    2,478 
Stock-based compensation   2,080    2,691 
Capitalized research expenses   1,902    2,547 
Depreciation and amortization   1,636    1,823 
Lease liability   -    124 
Accrued expenses   297    314 
Other   110    181 
Deferred tax assets   33,693    33,387 
Less: Valuation allowance   (33,693)   (33,274)
Net deferred tax asset  $-   $113 
           
Deferred tax liabilities:          
Right of Use Asset  $-   $(113)
Deferred tax liabilities  $-   $(113)
Total  $-   $-